Establishment of a FACS Assay for Screening of (TEMRA) Cells in Glioblastoma Patients

Scheer I, Becker I, Donaubauer AJ, Fietkau R, Gaipl U, Frey B (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Strahlentherapie und Onkologie Urban & Vogel

Publisher: SPRINGER HEIDELBERG

City/Town: HEIDELBERG

Pages Range: S89-S89

Conference Proceedings Title: STRAHLENTHERAPIE UND ONKOLOGIE

Authors with CRIS profile

Ina Becker Department of Radiation Oncology Anna-Jasmina Donaubauer Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Udo Gaipl Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology

How to cite

APA:

Scheer, I., Becker, I., Donaubauer, A.-J., Fietkau, R., Gaipl, U., & Frey, B. (2021). Establishment of a FACS Assay for Screening of (TEMRA) Cells in Glioblastoma Patients. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S89-S89). HEIDELBERG: SPRINGER HEIDELBERG.

MLA:

Scheer, I., et al. "Establishment of a FACS Assay for Screening of (TEMRA) Cells in Glioblastoma Patients." Proceedings of the STRAHLENTHERAPIE UND ONKOLOGIE HEIDELBERG: SPRINGER HEIDELBERG, 2021. S89-S89.

BibTeX: Download